C5ORF34 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.128800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.908800E-01
Normal-vs-Stage2
8.660600E-01
Normal-vs-Stage3
4.635200E-01
Normal-vs-Stage4
8.925400E-01
Stage1-vs-Stage2
1.636760E-01
Stage1-vs-Stage3
4.408200E-01
Stage1-vs-Stage4
7.336200E-01
Stage2-vs-Stage3
4.469800E-01
Stage2-vs-Stage4
7.712400E-01
Stage3-vs-Stage4
3.712600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.244200E-01
Normal-vs-AfricanAmerican
9.508600E-01
Normal-vs-Asian
5.386000E-01
Caucasian-vs-AfricanAmerican
8.380800E-01
Caucasian-vs-Asian
5.113000E-01
AfricanAmerican-vs-Asian
3.912800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.777400E-01
Normal-vs-Female
8.706200E-01
Male-vs-Female
4.406400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.033600E-01
Normal-vs-Age(41-60Yrs)
8.158600E-01
Normal-vs-Age(61-80Yrs)
9.861200E-01
Normal-vs-Age(81-100Yrs)
8.381800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.774800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.488400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.386800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.345600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.845360E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.207800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.848600E-01
Normal-vs-Daily Drinker
9.621200E-01
Normal-vs-Weekly Drinker
6.734200E-01
Normal-vs-Occasional Drinker
9.672000E-01
Normal-vs-Social Drinker
9.573000E-01
Non Drinker-vs-Daily Drinker
6.696000E-01
Non Drinker-vs-Weekly Drinker
3.345800E-01
Non Drinker-vs-Occasional Drinker
7.030600E-01
Non Drinker-vs-Social Drinker
6.872800E-01
Daily Drinker-vs-Weekly Drinker
3.686200E-01
Daily Drinker-vs-Occasional Drinker
9.982800E-01
Daily Drinker-vs-Social Drinker
9.974800E-01
Weekly Drinker-vs-Occasional Drinker
3.702200E-01
Weekly Drinker-vs-Social Drinker
3.679200E-01
Occasional Drinker-vs-Social Drinker
9.994400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.326600E-01
Normal-vs-Grade 2
5.475000E-01
Normal-vs-Grade 3
5.495000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.600250E-02
Grade 1-vs-Grade 3
1.520480E-02
Grade 1-vs-Grade 4
5.326600E-01
Grade 2-vs-Grade 3
6.827000E-01
Grade 2-vs-Grade 4
5.475000E-01
Grade 3-vs-Grade 4
5.495000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.417600E-01
Normal-vs-NonDiabetic
8.727600E-01
Diabetic-vs-NonDiabetic
1.371820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.061600E-01
Normal-vs-NoPancreatitis
9.385200E-01
Pancreatitis-vs-NoPancreatitis
2.078600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.757000E-01
Normal-vs-N1
8.834000E-01
N0-vs-N1
4.633600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.200000E-01
Normal-vs-TP53-NonMutant
7.227200E-01
TP53-Mutant-vs-TP53-NonMutant
9.423300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
